$2.80
arrow_drop_up1.08%Key Stats | |
---|---|
Open | $2.82 |
Prev. Close | $2.77 |
EPS | -0.78 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $172.51M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.71 | 2.82 |
52 Week Range | 1.56 | 4.27 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.78 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
Wall Street Breakfast: The Week Ahead
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?